Skip to main content

Bionano Genomics, Inc.

corporate_fare Company Profile

Bionano Genomics, Inc.

BNGO·NASDAQ·Industrial Applications And Services·CIK 0001411690

Bionano Genomics, Inc. provides genome analysis solutions that help researchers and clinicians find answers in biology and medicine. The company aims to transform how the world views the genome using optical genome mapping ("OGM") solutions, nucleic acid extraction and purification systems, diagnostic services, and software. Bionano Genomics offers OGM solutions for basic, translational, and clinical research, as well as bioprocessing. Its platform-agnostic software integrates next-generation sequencing ("NGS"), microarray, and OGM data to analyze, visualize, interpret, and report copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in a single view. The company also provides nucleic acid extraction and purification solutions using its proprietary isotachophoresis ("ITP") technology. Through its Bionano Laboratories business, it offers OGM-based diagnostic testing services. The company develops, manufactures, markets, and sells OGM systems, including the Saphyr® system and the Stratys system. These systems provide OGM data for ultra-sensitive and ultra-specific detection of all classes of structural variation ("SV"). They are used to identify structural changes in chromosomes (cytogenetics) and to accelerate research in genetic disease, cancer, and cell and gene therapy applications. The systems consist of an instrument, chip consumables, reagents, and software with data analysis and visualization tools. OGM has demonstrated superior performance compared to current cytogenetic methods like karyotyping, fluorescence in-situ hybridization ("FISH"), Southern blot, and chromosomal microarray ("CMA") for SV detection, and can identify structural changes in chromosomes not detectable by current commercial gene sequencing solutions. Bionano Genomics also develops, manufactures, markets, and sells the Ionic® Purification system, which delivers high-quality DNA in a more natural, native form with fewer contaminants than other isolation and purification solutions.

Bionano Genomics, Inc. (NASDAQ:BNGO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 19 items for BNGO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 10/10, with 15 rated 8 or above. Recent SEC coverage for BNGO spans 8-K, 10-Q, S-3, 10-K.

Recent high-impact activity:

  • Bionano Projects 56% Revenue Growth in FY27, EBITDA Break-Even by Q4 FY27
  • Bionano Q2 revenue climbs 21%, but going concern warning persists as cash dwindles to $3.7M
  • Bionano Q2 Revenue Jumps 21% to $8.2M, Guides FY26 Revenue to $31-33M
  • Bionano Genomics Appoints Alex Hastie as Chief Scientific Officer
  • Bionano's OGM Studies Surge 67% at ESHG 2026, Signaling Expanding Global Adoption

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$28.51M
Net Income
-$26.39M
Diluted EPS
-$4.85
Op. Cash Flow
-$16.34M
Gross Profit
$13.19M
Operating Income
-$33.34M
Cash & Equivalents
$2.99M
Debt / Equity
0.00×
Net Margin
-92.6%
Shares Outstanding
10.74M sh
Source: 10-K · filed 2026-03-23 · accession 0001411690-26-000007

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,144,194 shares in BNGO as of the September 15, 2026 settlement, a 6.5% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 56.6% of BNGO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,144,194 shares as of September 15, 2026
Change vs prior period▼ 6.5%
Days to cover1.00 at avg daily volume of 4,141,332
Daily short volume (FINRA facilities)56.6% of 234,715 shares on October 2, 2026
5-day average short volume55.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for BNGO, detected from its recent SEC filings.

1 shelf registration

New Universal Shelf Registration Filed · Addresses Going Concern Warning

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with B →
$1.5 +0.02% today
52-week range · as of 2026-09-14 $1 – $5.5
Market cap
$17.43M
Volume
384.2K (0.2× avg)
3-mo avg 1.8M
Live data · 2026-10-05 03:57 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BNGO - Latest Insights

BNGO
Sep 14, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $1.50 info
Change: +$0.2607 (+21%) info
Market Cap: $17.43M info
BNGO
Aug 10, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.17
Real-time Price: $1.50 info
Change: +$0.3304 (+28%) info
Market Cap: $17.43M info
BNGO
Aug 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.50 info
Change: +$0.3305 (+28%) info
Market Cap: $17.43M info
BNGO
Jun 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $1.50 info
Change: +$0.350 (+30%) info
Market Cap: $17.43M info
BNGO
Jun 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $1.50 info
Change: +$0.3312 (+28%) info
Market Cap: $17.43M info
BNGO
Jun 05, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.50 info
Change: +$0.330 (+28%) info
Market Cap: $17.43M info
BNGO
Jun 05, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.50 info
Change: +$0.330 (+28%) info
Market Cap: $17.43M info
BNGO
May 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $1.27
Real-time Price: $1.50 info
Change: +$0.230 (+18%) info
Market Cap: $17.43M info
BNGO
May 13, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.32
Real-time Price: $1.50 info
Change: +$0.180 (+14%) info
Market Cap: $17.43M info
BNGO
May 13, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $1.50 info
Change: +$0.2001 (+15%) info
Market Cap: $17.43M info
BNGO
May 13, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.25
Real-time Price: $1.50 info
Change: +$0.250 (+20%) info
Market Cap: $17.43M info
BNGO
May 08, 2026, 4:02 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $1.29
Real-time Price: $1.50 info
Change: +$0.210 (+16%) info
Market Cap: $17.43M info
BNGO
May 06, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.28
Real-time Price: $1.50 info
Change: +$0.220 (+17%) info
Market Cap: $17.43M info
BNGO
May 05, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $1.50 info
Change: +$0.290 (+24%) info
Market Cap: $17.43M info
BNGO
Apr 02, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.19
Real-time Price: $1.50 info
Change: +$0.3099 (+26%) info
Market Cap: $17.43M info
BNGO
Mar 23, 2026, 4:08 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.56
Real-time Price: $1.50 info
Change: -$0.060 (-4%) info
Market Cap: $17.43M info
BNGO
Mar 23, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.60
Real-time Price: $1.50 info
Change: -$0.100 (-6%) info
Market Cap: $17.43M info
BNGO
Mar 17, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.09
Real-time Price: $1.50 info
Change: +$0.410 (+38%) info
Market Cap: $17.43M info
BNGO
Jan 12, 2026, 8:15 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.58
Real-time Price: $1.50 info
Change: -$0.080 (-5%) info
Market Cap: $17.43M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets